| Dr Jessica Kristine Doherty, PHARMD | |
|
2900 12th Ave N Ste 503e, Billings, MT 59101-7502 | |
| (406) 237-5780 | |
| (406) 237-5785 |
| Full Name | Dr Jessica Kristine Doherty |
|---|---|
| Gender | Female |
| Speciality | Pharmacist - Pharmacist Clinician (phc)/ Clinical Pharmacy Specialist |
| Location | 2900 12th Ave N Ste 503e, Billings, Montana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1669150504 | NPI | - | NPPES |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jessica Kristine Doherty, PHARMD 2900 12th Ave N Ste 503e, Billings, MT 59101-7502 Ph: (406) 237-5780 | Dr Jessica Kristine Doherty, PHARMD 2900 12th Ave N Ste 503e, Billings, MT 59101-7502 Ph: (406) 237-5780 |
News Archive
Federal health officials will likely reject Montana's request to include work requirements for beneficiaries of its Medicaid expansion program, which insures 100,000 low-income Montana adults, state officials said.
In a recent study published in "Scientific Reports", an international team of researchers led by MedUni Vienna report that an oxytocin-like neuropeptide ("inotocin") exhibited a specific pharmacological profile for the human receptors of oxytocin (known as the "love hormone") and vasopressin.
The National Institutes of Health (NIH) awarded Professor Mahesh Mohan, D.V.M., Ph.D., and collaborators more than $3.5 million over five years to investigate the effects of cannabinoids on Human Immunodeficiency Virus (HIV) associated neurocognitive disorder (HAND).
When COVID-19 started depleting stockpiles of medical gear in hotspots like New York and New Jersey, the West Virginia National Guard took notice - and reached out to experts at the John Chambers College of Business and Economics at West Virginia University to help prevent that from happening in the Mountain State.
Treatment options for idiopathic OAB patients not adequately managed by anticholinergic therapy are limited; either highly invasive, expensive or of limited efficacy. BOTOX® (onabotulinumtoxinA) may provide a minimally invasive effective treatment. Professor Chris Chapple and his group conducted the first large, double-blind, placebo-controlled, dose ranging study to systematically asses the benefit/risk balance of the use of BOTOX® in IOAB across a wide range of doses.
› Verified 2 days ago
Hannah Elizabeth Johnson, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1649 Main St, Billings, MT 59105 Phone: 406-254-2842 | |
David Sanks, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2525 King Ave W, Billings, MT 59102 Phone: 406-652-9688 | |
Joshua Teynor, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1602 Main St, Billings, MT 59105 Phone: 406-245-0178 | |
Gerald Robbin Fisher, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3333 Grand Ave, Billings, MT 59102 Phone: 406-652-1620 | |
Dr. Natalie Marie Waterfall, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 670 Main St, Billings, MT 59105 Phone: 406-245-6979 | |
Barbara Metzger, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2290 King Ave W, Billings, MT 59102 Phone: 406-656-8556 | |
Kailey Klinger, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1775 Spring Creek Lane, Billings, MT 59102 Phone: 406-373-3500 Fax: 406-373-3607 |